Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study
Julia W. Haas, Giulio Ongaro, Eric Jacobson, et al.
BMC Psychology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Expectancy Effects in Psychedelic Trials
Balázs Szigeti, Boris D. Heifets
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 512-521
Closed Access | Times Cited: 23
INVESTIGATION OF NOISE IMMUNITY OF A MULTICHANNEL UNDERWATER WIRELESS OPTICAL COMMUNICATION SYSTEM
Ivan V. Semernik, Christina V. Samonova
(2024)
Closed Access | Times Cited: 16
МATHEMATICAL MODEL OF A BEE COLONY BY GENDER IN A STATIONARY CASE
I.M. Saidzoda
(2024)
Closed Access | Times Cited: 8
Placebo: a brief updated review
Alfredo José Pardo-Cabello, Victoria Manzano‐Gamero, E. Puche-Cañas
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 11, pp. 1343-1356
Open Access | Times Cited: 23
A systematic qualitative review of ethical issues in open label placebo in published research
Mélina Richard, Michael H. Bernstein, Jens Gaab, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Neural underpinnings of open-label placebo effects in emotional distress
Michael Schaefer, Anja Kühnel, Felix Schweitzer, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 3, pp. 560-566
Open Access | Times Cited: 15
No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial
Julian Kleine‐Borgmann, Tim-Niklas Dietz, Katharina Schmidt, et al.
Pain (2022) Vol. 164, Iss. 3, pp. 645-652
Open Access | Times Cited: 12
The pill you don’t have to take that is still effective: neural correlates of imaginary placebo intake for regulating disgust
Anne Schienle, Wolfgang Kogler, Arved Seibel, et al.
Social Cognitive and Affective Neuroscience (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Open-label placebos reduce weight in obesity: a randomized controlled trial
Michael Schaefer, Anja Kühnel, Sören Enge
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
“Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial
Yiqi Pan, Miriam L. Frank, Ted J. Kaptchuk, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0276499-e0276499
Open Access | Times Cited: 8
A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis
Michael Schaefer, Kurt Zimmermann, Paul Enck
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Open-label placebo is an evidence-based treatment option for many chronic conditions
Sarah Ballou, Tobias Kube
Pain (2024) Vol. 165, Iss. 2, pp. 487-488
Closed Access | Times Cited: 1
Patient-Physician Relationship in Irritable Bowel Syndrome: Review on Empathy and Stigma
Irma Kuliavienė, Sigita Gelman, Juozas Kupčinskas
Journal of Gastrointestinal and Liver Diseases (2024) Vol. 33, Iss. 1, pp. 107-114
Open Access | Times Cited: 1
Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery
Valerie Hruschak, K. Mikayla Flowers, Megan E Patton, et al.
International Journal of Behavioral Medicine (2022) Vol. 30, Iss. 4, pp. 509-521
Closed Access | Times Cited: 6
Evidencing general acceptability of open-label placebo use for tackling overtreatment in primary care: a mixed methods study
Eva M. Krockow, T. E. Emerson, Elaney Youssef, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Pretending to care
Doug Hardman
Journal of Medical Ethics (2022) Vol. 49, Iss. 7, pp. 506-509
Closed Access | Times Cited: 5
Doctors Speak: A Qualitative Study of Physicians’ Prescribing of Antidepressants in Functional Bowel Disorders
Giulio Ongaro, Sarah Ballou, Tobias Kube, et al.
Culture Medicine and Psychiatry (2022) Vol. 47, Iss. 3, pp. 669-683
Closed Access | Times Cited: 3
Open-label placebos enhance test performance and reduce anxiety in learner drivers: a randomized controlled trial
Michael Schaefer, Sören Enge
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Development and psychometric evaluation of the Hope in Medicine scale
Lea Balthasar, Anne‐Kathrin Bräscher, Ted J. Kaptchuk, et al.
Clinical Psychology in Europe (2024) Vol. 6, Iss. 1
Open Access
HYPERESTHESIA OF HARD TISSUE OF TEETH DURING GUM RECESSION - PREVENTION AND TREATMENT
Н.В. Чиркова, В.А. Токарев, K.E. Chirkova
(2024)
Closed Access
ASPECTS OF XENON ANALGESIA ON EARTH AND IN SPACE
F. M. Shvetskiy, С. М. Козлов, L.B. Volokitin
(2024)
Closed Access
“HIDDEN POWERS!”... RELIGION IN THE LIFE AND WORK OF M. MUSORGSKY
Olga Gladkova
(2024)
Closed Access
FEATURES OF CHANGES IN THE CIRCADIAN RHYTHM OF TOTAL PERIPHERAL VASCULAR RESISTANCE DURING THE ANURIC PHASE OF ACUTE RENAL FAILURE IN CHILDREN AGED 3.1-7 YEARS
H.N. Muhitdinova, H.S. Ismoilov, K. A. Kim
(2024)
Closed Access
ADAPTIVE LANDSCAPE FARMING IN VEGETABLE GROWING IN THE SOUTH OF THE RUSSIAN FAR EAST
N. A. Sakara, В. И. Ознобихин, Т.С. Тарасова
(2024)
Closed Access
HYPNOSIS AND SUGGESTION IN THE DOMINANT MECHANISMS OF ACADEMICIAN UKHTOMSKY WITH PLACEBO EFFECT IN TREATMENT AND REHABILITATION
V.N. Ananiev, N.Y. Prokopyev, O.V. Ananieva, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top